Search for: "Nature's Way Products, Inc. v. Nature-Pharma, Inc."
Results 1 - 20
of 59
Sorted by Relevance
|
Sort by Date
17 Aug 2015, 5:03 am
That means that other parties will not be hindered in developing technologies which also make use of the same judicial exception.Ariosa Diagnostics v SequenomAriosa Diagnostics, Inc. v Sequenom, Inc., No. 2014-1139 (Fed. [read post]
18 Jan 2013, 2:06 pm
The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
18 Jul 2014, 11:55 am
If any of our readers know of any innovator liability decisions that we have missed, by all means send them along.AlabamaIt’s not a bad thing to get the worst out of the way at the beginning. [read post]
26 Jun 2008, 6:31 pm
Mo. 2002); see generally Schwarz Pharma, Inc. v. [read post]
29 Jul 2015, 11:30 am
Physicians Healthsource, Inc. v. [read post]
18 Aug 2020, 11:30 am
Ixchel Pharma, LLC v. [read post]
29 Oct 2013, 9:55 am
See, e.g., Purdue Pharma L.P. v. [read post]
10 Feb 2017, 9:54 am
Watson Pharma (Fed. [read post]
20 Nov 2012, 7:50 am
This is an appeal against the General Court's decision in Case T-321/05 that the pharma company had breached EU antitrust provisions in seeking to keep a generic competitor off the market for its products, armed with nothing more than some useful patent rights, a vivid imagination and a determination to apply its own, surprisingly plausible interpretation of some less-than-specific provisions of European law. [read post]
22 Oct 2017, 11:16 am
ICON Healthy & Fitness, Inc., 134 S. [read post]
10 Mar 2016, 6:49 am
In Amarin Pharma, Inc. v. [read post]
10 Mar 2016, 6:49 am
In Amarin Pharma, Inc. v. [read post]
10 Mar 2016, 6:49 am
In Amarin Pharma, Inc. v. [read post]
22 Jul 2008, 7:51 pm
See Aventis Pharma Deutschland GmbH v. [read post]
17 Jul 2017, 3:18 pm
Millennium Pharma v. [read post]
5 Apr 2023, 5:18 am
Additionally, the judgment suggested in obiter that arbitration may be a more effective way of dealing with global FRAND disputes than through national courts. 6) Wines by Otsuka In Otsuka Pharmaceutical Co Ltd v GW Pharma Ltd [2022] EWHC 1012 (Pat), Deputy High Court Judge Ian Karet rejected a challenge to the court’s jurisdiction to determine a claim for royalties under a research collaboration and licence agreement between Otsuka, a Japanese pharmaceutical… [read post]
8 Apr 2014, 8:02 am
In ABC, Inc. v. [read post]
1 Apr 2016, 8:22 am
Flexible Obviousness Test Does Not Apply to Secondary Indicia of Nonobviousness: In Cubist Pharma v. [read post]
16 Aug 2012, 8:42 am
Prometheus Laboratories, Inc., 132 S. [read post]
3 Sep 2015, 3:06 pm
EndoPharmaceuticals Inc., 438 F.3d 1123, 1134 (Fed. [read post]
